Bio-Rad Laboratories Inc (BIO)
293.96
-1.77
(-0.60%)
USD |
NYSE |
May 17, 16:00
293.96
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories Debt to Equity Ratio: 0.1315 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.1315 |
December 31, 2023 | 0.1372 |
September 30, 2023 | 0.1413 |
June 30, 2023 | 0.1419 |
March 31, 2023 | 0.1228 |
December 31, 2022 | 0.1246 |
September 30, 2022 | 0.1404 |
June 30, 2022 | 0.133 |
March 31, 2022 | 0.1165 |
December 31, 2021 | 0.0008 |
September 30, 2021 | 0.0001 |
June 30, 2021 | 0.0001 |
March 31, 2021 | 0.0001 |
December 31, 2020 | 0.0003 |
September 30, 2020 | 0.0484 |
June 30, 2020 | 0.0581 |
March 31, 2020 | 0.0679 |
December 31, 2019 | 0.0744 |
September 30, 2019 | 0.0834 |
June 30, 2019 | 0.078 |
March 31, 2019 | 0.0879 |
December 31, 2018 | 0.1093 |
September 30, 2018 | 0.0899 |
June 30, 2018 | 0.095 |
March 31, 2018 | 0.0969 |
Date | Value |
---|---|
December 31, 2017 | 0.1485 |
September 30, 2017 | 0.1527 |
June 30, 2017 | 0.1547 |
March 31, 2017 | 0.1606 |
December 31, 2016 | 0.1685 |
September 30, 2016 | 0.1607 |
June 30, 2016 | 0.1661 |
March 31, 2016 | 0.1707 |
December 31, 2015 | 0.1743 |
September 30, 2015 | 0.1795 |
June 30, 2015 | 0.1848 |
March 31, 2015 | 0.1983 |
December 31, 2014 | 0.1995 |
September 30, 2014 | 0.2009 |
June 30, 2014 | 0.1944 |
March 31, 2014 | 0.1959 |
December 31, 2013 | 0.20 |
September 30, 2013 | 0.2058 |
June 30, 2013 | 0.3547 |
March 31, 2013 | 0.3615 |
December 31, 2012 | 0.3643 |
September 30, 2012 | 0.3786 |
June 30, 2012 | 0.3957 |
March 31, 2012 | 0.3983 |
December 31, 2011 | 0.42 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0001
Minimum
Mar 2021
0.1419
Maximum
Jun 2023
0.08
Average
0.0807
Median
Debt to Equity Ratio Benchmarks
Agilent Technologies Inc | 0.4129 |
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 0.5175 |
Bionano Genomics Inc | 0.3513 |
Akoya Biosciences Inc | 2.306 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 12.61B |
Total Liabilities (Quarterly) | 3.559B |
Shareholders Equity (Quarterly) | 9.051B |
Current Ratio | 6.566 |
Net Debt Paydown Yield | 0.02% |